Chan Henry Lik-Yuen, Wong May Ling, Hui Alex Yui, Hung Lawrence Cheung-Tsui, Chan Francis Ka-Leung, Sung Joseph Jao-Yiu
Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong SAR, China.
J Clin Microbiol. 2003 Oct;41(10):4793-5. doi: 10.1128/JCM.41.10.4793-4795.2003.
Seventy-three chronic hepatitis B patients who had either hepatitis B e antigen (HBeAg) seroconversion (group I) or HBeAg-negative disease (group II) were studied. HBV DNA levels at HBeAg seroconversion (group I) and at initial visits (group II) were significantly lower among patients who were persistently negative for HBeAg than among those who underwent HBeAg reversion.
对73例慢性乙型肝炎患者进行了研究,这些患者分为两组,一组是乙肝e抗原(HBeAg)血清学转换者(第一组),另一组是HBeAg阴性疾病患者(第二组)。在HBeAg血清学转换时(第一组)以及初次就诊时(第二组),HBeAg持续阴性的患者的HBV DNA水平显著低于发生HBeAg血清学逆转的患者。